[3] [4] Signs and symptoms [edit] Withdrawal symptoms occur during dose reduction and may include insomnia, anxiety, distress, weight loss, dizziness, night sweats, shaking, muscle twitches, aphasia, panic attacks, depression, numbness, dissociation, paranoia, indigestion, diarrhea, and photophobia
doi: 10.1016/j.bbalip.2020.158662 166 HarariALeikin FrenkelABarshackISageeACohenHKamariYet al
Participants receiving retatrutide 12 mg experienced 16.9% WL vs
Orem, UT June 9, 2026 DietsMD.com, an online medical weight loss platform specializing in doctor-guided GLP-1 treatment programs, today announced the expansion of its telehealth weight loss services designed to help eligible patients explore semaglutide, tirzepatide, and emerging oral GLP-1 treatment options through a streamlined online experience